Zapping acupoints may ease period pain for autoimmune patients
NCT ID NCT06976151
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether transcutaneous electrical acupoint stimulation (TEAS) — a gentle electrical pulse applied to specific points on the body — could reduce period pain and inflammation in women with autoimmune diseases like rheumatoid arthritis or lupus. Fifty-two women received either standard painkillers alone or painkillers plus TEAS sessions three times a week. Researchers measured pain, walking speed, and blood markers of inflammation over three menstrual cycles.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Transcutaneous electrical acupoint stimulation (TEAS) plus diclofenac (NSAID)
- What this could lead to
- If it works, this could offer a drug-free add-on to help manage painful periods in women with autoimmune conditions.
- What could go wrong
- This is a small, completed trial with only 52 participants, so results may not apply to everyone. The treatment is an add-on to standard painkillers, not a replacement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lamiaa Mostafa Okeil
Al Fayyum, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Strumming for the brain: could ukulele lessons sharpen minds in MS?
- Could music be medicine for the injured brain?
- Can a new shoulder implant restore Pain-Free movement?
- Can a less invasive hip surgery speed up recovery?
- Which hip implant lasts longer? a Head-to-Head trial aims to find out
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers